The report provides a detailed analysis essential for establishing a Letrozole production plant. It encompasses all critical aspects necessary for Letrozole production, including the cost of Letrozole production, Letrozole plant cost, Letrozole production costs, and the overall Letrozole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Letrozole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Letrozole is an FDA-approved oral, non-steroidal medication that is utilized in the medical and pharmaceutical industries. It majorly finds its application as an antineoplastic agent in the treatment of hormonally responsive breast cancer in postmenopausal women by inhibiting certain enzymes. Moreover, it is also used to induce ovulation in women with ovulatory disorders during fertility treatments. Additionally, it is also used as a medication by athletes and bodybuilders during a steroid cycle to reduce bloating due to excess water retention and prevent potential side effects of some anabolic steroids.
The market for Letrozole is driven by its utilization as a hormone therapy drug for the treatment of hormonally responsive breast cancer, which significantly promotes its demand in the medical and pharmaceutical industries. Moreover, its application as a medicine for fertility treatment in women further enhances its demands in the medical industry. Additionally, its use during a steroid cycle by athletes to prevent steroid-related side effects effectively boosts its market expansion. Furthermore, several factors influence industrial Letrozole procurement, such as the availability of raw materials (1H-1,2,4-triazole, etc.), cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Letrozole Production
According to the Letrozole production plant project report, the major raw materials for Letrozole production include 4-(Chloro(4-cyanophenyl)methyl)benzamide-1H-1,2,4-Triazole.
Production Process of Letrozole
The extensive Letrozole production cost report consists of the following industrial production process:
- Production via Amide Dehydration: This method of production involves a complete 5-stage synthetic process, including the amide dehydration in 1.4-dioxane by using a suitable dehydrating agent to obtain Letrozole as the product. In this method, the key step of the production involves the condensation of 4-(chloro(4-cyanophenyl)methyl)benzamide with 1H-1,2,4-triazole, followed by its dehydration in the presence of trifluoroacetic anhydride at low temperature, which results in the formation of Letrozole as the final product.
Letrozole belongs to the family of triazoles and benzonitrile, which is a third-generation aromatase inhibitor. Moreover, the molecular formula of the compound is C17H11N5, and its molecular weight is 285.30 g/mol. The trade name of the drug is Femara. This medication is provided along with osteoporosis-fighting medications to avoid the risk of osteoporosis. The IUPAC name of the compound is 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile. Additionally, the compound appears as an odorless yellowish-white crystalline powder with a melting point of around 184-185 °C. It is insoluble in water but gets immediately dissolved in dichloromethane.
